Posts by: Alice Melao

News

Using topical creams with high corticosteroid concentrations to manage skin rash in infants can lead to the development of drug-related secondary Cushing’s syndrome, a case report shows. Therefore, the ... Read more

July 23, 2019

Recordati Acquires Global Rights Over Signifor and Osilodrostat

News

Recordati has acquired worldwide rights over Novartis‘ investigational therapy osilodrostat (LCI699), being developed for the treatment of endogenous Cushing’s disease. The agreement also covers Signifor (pasireotide), an approved treatment for ... Read more

July 16, 2019

Pituitary Tissue Analysis During Surgery Improves Cushing’s Diagnosis, Study Says

News

Pituitary gland tissue analysis during surgery can help confirm a Cushing’s disease diagnosis and define the best strategy to treat patients with small pituitary tumors, according to a study. ... Read more

June 27, 2019

Researchers Report Rare Case of Cushing’s Caused by Bilateral Adrenal Tumors

News

Cases of adrenocorticotropic hormone (ACTH)-independent Cushing’s syndrome are often caused by unilateral tumors in the adrenal glands, but Indian researchers have now reported a rare case where the condition ... Read more

April 2, 2019

Phase 2 Trial to Assess Osilodrostat as Treatment for Children with Cushing’s Disease

News

Novartis is launching a Phase 2 trial to assess the safety and efficacy of its investigational therapy osilodrostat — an inhibitor of cortisol synthesis — in children with Cushing’s disease. ... Read more

March 12, 2019

Arterial Blood Clots May Be First Sign of Cushing’s Syndrome, Case Report Shows

News

In rare cases, the appearance of blood clots in arteries may be the first symptom of Cushing’s syndrome, a case report shows. That finding, “Arterial thrombosis as primary presentation ... Read more

March 7, 2019

Targeted Radiosurgery Suitable for Youngsters with Cushing’s Disease and Acromegaly, Study Shows

News

Stereotactic radiosurgery — a targeted form of radiation therapy — can effectively reduce hormone levels and control tumor progression in children and adolescents with hormone-secreting pituitary adenomas, particularly those ... Read more

March 5, 2019

Cushing’s Syndrome Patients at High Risk of Bone Problems Regardless of Vitamin D Levels, Study Shows

News

Cushing’s syndrome patients have a higher risk of fractures due to reduced bone mineral density and osteoporosis, but these issues are not associated with vitamin D or parathyroid hormone ... Read more

February 26, 2019

Long-term ACTH Exposure Causes Recurrence in Surgically Managed Cushing’s Patient

News

Long-term exposure to high levels of the adrenocorticotropic hormone (ACTH) may lead to a recurrence of Cushing’s disease even after surgical treatment, according to a case report. Detailed guidelines ... Read more

January 8, 2019

Corcept to Receive US Patent on Use of Korlym Plus CYP3A Inhibitors to Treat Cushing’s

News

Corcept Therapeutics has received notice that it will be issued a new patent in the U.S. covering the use of Korlym (mifepristone), in combination with strong CYP3A inhibitors, to treat ... Read more

Posts by: Alice Melao

Alice Melao

Corticosteroid-based Creams Can Cause Secondary Cushing’s Syndrome in Infants, Case Report Shows

Recordati Acquires Global Rights Over Signifor and Osilodrostat

Pituitary Tissue Analysis During Surgery Improves Cushing’s Diagnosis, Study Says

Researchers Report Rare Case of Cushing’s Caused by Bilateral Adrenal Tumors

Phase 2 Trial to Assess Osilodrostat as Treatment for Children with Cushing’s Disease

Arterial Blood Clots May Be First Sign of Cushing’s Syndrome, Case Report Shows

Targeted Radiosurgery Suitable for Youngsters with Cushing’s Disease and Acromegaly, Study Shows

Cushing’s Syndrome Patients at High Risk of Bone Problems Regardless of Vitamin D Levels, Study Shows

Long-term ACTH Exposure Causes Recurrence in Surgically Managed Cushing’s Patient

Corcept to Receive US Patent on Use of Korlym Plus CYP3A Inhibitors to Treat Cushing’s

Pin It on Pinterest